EP2612888A1 — A modified collagen
Assigned to INNOCOLL PHARMACEUTICALS LIMITED · Expires 2013-07-10 · 13y expired
What this patent protects
The present invention relates to a modified collagen obtainable by providing isolated collagen, optionally an isolated collagen dispersion; freezing the isolated collagen; and dehydrating the frozen isolated collagen. The present invention also relates to a method for preparing a…
USPTO Abstract
The present invention relates to a modified collagen obtainable by providing isolated collagen, optionally an isolated collagen dispersion; freezing the isolated collagen; and dehydrating the frozen isolated collagen. The present invention also relates to a method for preparing a modified collagen, the method comprising the steps of providing isolated collagen; freezing the isolated collagen; and dehydrating the frozen collagen. Also disclosed are compositions comprising a modified collagen according to the present invention, uses thereof, and methods for the manufacture thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.